methocel süstelahus
celon laboratories limited - metotreksaat - süstelahus - 25mg 1ml 2ml 10tk
vascel süstelahus
celon laboratories limited - argipressiin - süstelahus - 20rÜ 1ml 1ml 5tk
alkacel süstelahuse pulber ja lahusti
celon laboratories limited - melfalaan - süstelahuse pulber ja lahusti - 50mg 1tk
dacilon süstelahuse pulber
celon laboratories limited - daktinomütsiin - süstelahuse pulber - 0,5mg 1tk
bleocel 15 süstelahuse pulber
celon laboratories pvt. ltd., - bleomütsiin - süstelahuse pulber - 15000rÜ 1tk
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastilised ained - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
vinlon 1 süstelahus
celon laboratories pvt. ltd., - vinkristiin - süstelahus - 1mg 1ml 1ml 1tk
amfight süstelahuse pulber
celon laboratories pvt. ltd., - amfoteritsiin - süstelahuse pulber - 50mg 1tk
ambilon 50 infusioonilahuse pulber
celon laboratories pvt. ltd., - amfoteritsiin - infusioonilahuse pulber - 50mg 1tk
daunocyte infusioonilahuse pulber ja lahusti
celon laboratories pvt. ltd., - daunorubitsiin - infusioonilahuse pulber ja lahusti - 20mg 1tk